To evaluate this hypothesis , @ patients with severe heart failure due to a nonischemic cardiomyopathy ( ejection fraction < @ % ) were randomly assigned to amlodipine ( target dose : @ mg/d ) or placebo added to conventional therapy for heart failure for a median of @ months .